Illumina, Inc. (ILMN)

Nasdaq · Healthcare · Diagnostics & Research
$192.82-3.90%As of 2026-11-22 · USD
Last session low $191.28Last session high $199.24
52-week low $112.6552-week high $309.35
Market cap
$29.15B
Sector
Healthcare
P/E (TTM)
33.2x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)34.3In the neutral range (30 to 70)
MACD (12, 26, 9)-15.46Below its signal line (-13.05); histogram -2.41
Bollinger %B (20, 2)21%Inside the bands (167.88 to 287.07)
SMA 20227.47Price is 15.2% below
SMA 50248.31Price is 22.3% below
SMA 200181.10Price is 6.5% above
ATR (20)7.13% of priceAverage true range per day
52-week position41%In the middle of the 112.65 to 309.35 range

About Illumina, Inc.

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Insider filings, 90 daysNo purchases and 12 sales (about $270.2M).
Latest fiscal yearEnded 2025-12-31: revenue of $4.34B and an operating margin of 18.8%.

More in Diagnostics & Research